← 返回

用于发现慢性髓系白血病缓解结局相关 NK 细胞基因特征的 AI 单细胞转录组分析流程

英文原题:An AI-Enabled Single-Cell Transcriptomic Analysis Pipeline for Gene Signature Discovery in Natural Killer Cells Linked to Remission Outcomes in Chronic Myeloid Leukemia.

查看英文原题

An AI-Enabled Single-Cell Transcriptomic Analysis Pipeline for Gene Signature Discovery in Natural Killer Cells Linked to Remission Outcomes in Chronic Myeloid Leukemia.

PubMed 2026/04/06(内容时间) Biology (Basel) Q1 · IF 4.3(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

这项 AI 驱动的单细胞分析展示了 NK 细胞状态组成、分化轨迹和调控网络重塑如何共同塑造 CML 中 TKI 停药后的 TFR 与复发。该整合分析流程提供了一个模块化框架,可扩展至更多数据集,用于数据驱动的生物标志物发现和机制分层,并突出了候选转录调控因子和 NK 细胞程序,或可加以利用以改善缓解的持久性,有待在更大规模的患者队列中验证。

研究思路结论见上方概要

单细胞转录组学的一项重大技术挑战在于缺乏一种整合性分析流程,能够同时利用基因调控网络(GRN)架构、AI 辅助的基因panel 发现以及功能相关性分析,从而产生连贯一致的生物学洞见。现有方法通常将这些组成部分独立处理,仅聚焦于细胞簇、标志基因或预测特征,而未将其整合进一个具有机制基础的框架中。因此,在单细胞数据集内将调控关联、基因签名筛查与功能解读相联系的综合筛查仍然有限,凸显了对整合性策略的需求。

我们开发了一个基于基因调控网络-AI-功能分析(GAFA)的整合生物信息学流程,结合了潜在空间整合、无监督聚类、扩散拟时序分析、谱系解析的广义可加模型、GRN 推断以及基于机器学习的基因组合发现。该框架能够系统性地绘制细胞状态结构图谱、重建分化与效应轨迹,并识别与临床结局高度相关的转录和调控特征。作为案例研究,我们将该流程应用于六名 CML 患者(两例早期复发、两例晚期复发、两例持久无治疗缓解-TFR;共 15 份样本)在 TKI 停药时及停药后 6-12 个月采集的 NK 细胞转录组数据。

我们重新分析了此前发表的 CML 队列中公开可用的 scRNA-seq 数据,以评估与无治疗缓解和复发相关的 NK 细胞转录程序。我们解析出六种转录上截然不同的 NK 细胞状态,涵盖 CD56 bright 样细胞因子反应型、早期活化型、终末成熟型、细胞毒型、淋巴归巢型以及 HLA-DR + 免疫调节型群体,每种状态均表现出与结局相关的组成差异。拟时序分析揭示了 NK 细胞的两大主要谱系——一条成熟轨迹和一条细胞毒效应轨迹。TFR 样本显示两条谱系的均衡分布,而早期复发样本则表现出成熟分支的显著耗竭,并向细胞毒终末状态优先聚集。AI 引导的特征选择与随机森林建模鉴定出一个 18 基因组合,能以探索性方式区分来自 TFR 与复发样本的 NK 细胞。其中,CST7、FCER1G、GNLY、GZMA 和 HLA-C 为常规的 NK 相关基因,而 ACTB、CYBA、IFITM2、IFITM3、LYZ、MALAT1、MT2A、MYOM2、NFKBIA、PIM1、S100A8、S100B 和 TSC22D3 则为新发现的基因。GRN 推断进一步揭示了与结局相关的调控模块:RUNX3、EOMES、ELK4 和 REL 调控子在 TFR 中富集,而 FOSL2 和 MAF 调控子在复发中富集,其下游靶点与 IFN- 信号、代谢重编程以及免疫调节反馈回路相关。

展开英文摘要原文

A major technical challenge in single-cell transcriptomics is the absence of an integrative analytic pipeline that can simultaneously leverage gene regulatory network (GRN) architecture, AI-assisted gene panel discovery, and functional relevance analyses to generate coherent biological insights. Existing approaches often treat these components independently, focusing on clusters, marker genes, or predictive features without integrating them into a mechanistically grounded framework. Consequently, comprehensive screening that links regulatory association, gene signature screening, and functional interpretation within single-cell datasets remains limited, underscoring the need for an integrated strategy.

We developed an integrative bioinformatics pipeline based on Gene regulatory network-AI-Functional Analysis (GAFA), combining latent-space integration, unsupervised clustering, diffusion pseudotime analysis, lineage-resolved generalized additive modeling, GRN inference, and machine learning-based gene panel discovery. This framework enables systematic mapping of cell-state structure, reconstruction of differentiation and effector trajectories, and identification of transcriptional and regulatory features strongly associated with clinical outcomes. As a case study, we applied the pipeline to NK cell transcriptomes from six CML patients (two early relapse, two late relapse, two durable treatment-free remission-TFR; 15 samples) collected at TKI discontinuation and 6-12 months after therapy cessation.

We reanalyzed publicly available scRNA-seq data from a previously published CML cohort to evaluate NK-cell transcriptional programs associated with treatment-free remission and relapse. We resolved six transcriptionally distinct NK cell states spanning CD56 bright -like cytokine-responsive, early activated, terminally mature, cytotoxic, lymphoid trafficking, and HLA-DR + immunoregulatory populations, each exhibiting outcome-specific compositional differences. Pseudotime analysis revealed two major NK cell lineages-a maturation trajectory and a cytotoxic effector trajectory. TFR samples displayed balanced occupancy of both lineages, whereas early relapse samples showed marked depletion of the maturation branch and preferential accumulation in cytotoxic end states. AI-guided feature selection and random forest modeling identified an 18-gene panel that distinguished NK cells from TFR and relapse samples in an exploratory manner. Among them, CST7 , FCER1G , GNLY , GZMA , and HLA-C were conventional NK-associated genes, whereas ACTB , CYBA , IFITM2 , IFITM3 , LYZ , MALAT1 , MT2A , MYOM2 , NFKBIA , PIM1 , S100A8 , S100B , and TSC22D3 were novel. The GRN inference further uncovered outcome-specific regulatory modules, with RUNX3 , EOMES , ELK4 , and REL regulons enriched in TFR, whereas FOSL2 and MAF regulons were enriched in relapse, and their downstream targets linked to IFN- signaling, metabolic reprogramming, and immunoregulatory feedback circuits.

This AI-enabled single-cell analysis demonstrates how NK cell state composition, differentiation trajectories, and regulatory network rewiring collectively shape TFR versus relapse following TKI discontinuation in CML. The integrative pipeline provides a modular framework that could be extended to additional datasets for data-driven biomarker discovery and mechanistic stratification, and highlights candidate transcriptional regulators and NK cell programs that may be leveraged to improve remission durability, pending validation in larger patient cohorts.

论文信息

作者
Borra S、Yan D、Welner RS、Yue Z
第一作者单位
Department of Computer Sciences, Luddy School of Informatics, Computing, and Engineering (SICE), Indiana University, Bloomington, IN 47408, USA.United States
通讯作者单位
Department of Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA.United States
期刊
Biology2026 Apr 6
原文标识
PubMed 41972591 · DOI 10.3390/biology15070588